Symptoms, Diagnosis & Treatment Options for Mast Cell Disorders (Recording)
Enhance your clinical skills of Mast Cell Disorder to improve diagnosis, treatment, and patient quality of life.
Enhance your clinical skills of Mast Cell Disorder to improve diagnosis, treatment, and patient quality of life.
Enhance your patient education skills to reduce errors and improve outcomes in Contact Dermatitis care.
The Allergy & Asthma Network is deeply concerned with the Environmental Protection Agency’s (EPA) decision to reverse the Agency’s 2009 Endangerment Finding.
The LHHS Subcommittee has included language in its fiscal year 2026 Appropriations Bill calling for $33.5 million in funding for the Centers for Disease Control and Prevention’s (CDC) National Asthma Control Program (NACP).
Since epinephrine is essential for those at risk for severe allergic reactions, it’s important to know how to store the medication safely.
This summer and fall, Allergy & Asthma Network is joining the National Alliance for Hispanic Health to bring free respiratory health screenings and educational resources to cities across the country.
Mold allergy is very common. Asthma and allergy patients whose homes are affected by water damage should act immediately to dry things out.
Allergy & Asthma Network is deeply concerned for patients, hospitals and clinics with the enactment of the 2025 federal budget reconciliation bill
This webinar will provide evidence-based strategies for improving patient technique, adherence, and self-management.
Learn about OCS Overexposed: a new awareness campaign to help people understand the risks of long-term steroid use to treat asthma.
The focus of this study is to evaluate the efficacy of an investigational drug, EVO756, in adults with moderate to severe CSU, and how safely it interacts with the body. Participants will receive either the study drug or placebo in tablet form to take for 12 weeks and be evaluated on an outpatient basis. The…
June 16, 2025 The U.S. Food and Drug Administration (FDA) is warning of a rare side effect involving two oral allergy medications. Some people who stopped long-term use of the oral allergy medicines cetirizine or levocetirizine reported severe itching.. Cetirizine is marketed as the brand name Zyrtec®. Levocetirizine is marketed as Xyzal®. They are available…
End of content
End of content

10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Join Our Newsletter
Keep up with the latest news from AAN, right in your inbox! Choose from our eNewsletter, Research or EXHALE newsletters.
🔐 We do not share or sell your information.